Xtant Medical Holdings (XTNT) Change in Account Payables (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Change in Account Payables came in at -$399000.0 in Q3 2025, down 130.57% year-over-year from $1.3 million in Q3 2024, and down 4090.0% quarter-over-quarter from $10000.0 in Q2 2025.
Analysis
Xtant Medical Holdings (XTNT) Change in Account Payables (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Change in Account Payables for 16 consecutive years, with -$399000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Change in Account Payables fell 130.57% year-over-year to -$399000.0 in Q3 2025; TTM through Sep 2025 was -$1.5 million, a 151.68% decrease from a year earlier, with the FY2024 full-year figure at $1.0 million, down 65.34% from the prior year.
- Change in Account Payables was -$399000.0 for Q3 2025 at Xtant Medical Holdings, down from $10000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.7 million in Q4 2023 and troughed at -$890000.0 in Q1 2025.
- A 5-year average of $172473.7 and a median of $151000.0 in 2021 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 813.04% in 2024 and plunged 280.89% in 2025, its largest moves.
- Over 5 years, Change in Account Payables stood at $260000.0 in 2021, then slumped by 211.15% to -$289000.0 in 2022, then surged by 682.01% to $1.7 million in 2023, then slumped by 115.28% to -$257000.0 in 2024, then tumbled by 55.25% to -$399000.0 in 2025.
- The last three Change in Account Payables figures came in at -$399000.0 (Q3 2025), $10000.0 (Q2 2025), and -$890000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -399,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | -890,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | -507,000.00 |
| Mar 31, 2024 | 492,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 344,000.00 |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | -69,000.00 |
| Dec 31, 2022 | -289,000.00 |
| Sep 30, 2022 | 736,000.00 |
| Jun 30, 2022 | 269,000.00 |
| Mar 31, 2022 | 159,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | -284,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Mar 31, 2021 | -459,000.00 |
| Dec 31, 2020 | -525,000.00 |